AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22964761 — intervention group
Group type: COMPARATOR
Intervention: No-contact control group
Number of subjects: 0
Study 20864946 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (FA) treatment (5 mg/day for 4 weeks)
Number of subjects: 49
Study 20864946 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (FA) treatment
Number of subjects: 49
Study 20864946 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study 18466662 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational session, faxed reporting reminder, and newsletter
Number of subjects: 0
Study 18466662 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 18294107 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast 5-10 mg/day for 3-7 days
Number of subjects: 11
Study 18294107 — intervention group
Group type: COMPARATOR
Intervention: Albuterol (2 puffs of metered-dose inhaler just before exercise challenge)
Number of subjects: 11
Study 16087295 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal capsaicin injections
Number of subjects: 20
Study 16087295 — intervention group
Group type: COMPARATOR
Intervention: Intradermal saline placebo injections
Number of subjects: 20
Study 12407092 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride solution (44,800 ppm F) applied annually
Number of subjects: 375
Study 12407092 — intervention group
Group type: EXPERIMENTAL
Intervention: Silver diamine fluoride solution (44,800 ppm F) applied annually after removal of soft carious tissues
Number of subjects: 375
Study 12407092 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride varnish (22,600 ppm F) applied every three months
Number of subjects: 375
Study 12407092 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium fluoride varnish (22,600 ppm F) applied every three months after removal of soft carious tissues
Number of subjects: 375
Study 12407092 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 375
Study 10092314 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen supplementation (12 L/min for 9 hours)
Number of subjects: 15
Study 10092314 — intervention group
Group type: COMPARATOR
Intervention: Room air (control)
Number of subjects: 15
Study 7602344 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy containing cyclophosphamide
Number of subjects: 2638
Study 2379530 — intervention group
Group type: EXPERIMENTAL
Intervention: Domperidone (15 mg) followed by Pergolide (25 micrograms) after 1 hour
Number of subjects: 9
Study 2379530 — intervention group
Group type: COMPARATOR
Intervention: Placebo followed by Pergolide (25 micrograms) after 1 hour
Number of subjects: 9
Study 2379530 — intervention group
Group type: COMPARATOR
Intervention: Domperidone (15 mg) followed by Placebo after 1 hour
Number of subjects: 9
Study 373775 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide dinitrate and bupranolol
Number of subjects: 16
Study 31981856 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial ketamine infusions
Number of subjects: 50
Study 31981856 — intervention group
Group type: COMPARATOR
Intervention: ECT
Number of subjects: 50
Study 30716917 — intervention group
Group type: EXPERIMENTAL
Intervention: Petit-suisse cheese with Lactobacillus casei
Number of subjects: 0
Study 30716917 — intervention group
Group type: COMPARATOR
Intervention: Petit-suisse cheese without Lactobacillus casei (control)
Number of subjects: 0
Study 28323656 — intervention group
Group type: EXPERIMENTAL
Intervention: Loupe magnification (LM) for tumor margin assessment
Number of subjects: 93
Study 28323656 — intervention group
Group type: COMPARATOR
Intervention: Clinical examination alone (control)
Number of subjects: 93
Study 25599828 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic intervention (tailored intervention targeting individual cognition and self-regulation processes)
Number of subjects: 1349
Study 25599828 — intervention group
Group type: EXPERIMENTAL
Intervention: Plus intervention (basic intervention additionally targeting environmental-level factors)
Number of subjects: 1349
Study 25599828 — intervention group
Group type: COMPARATOR
Intervention: Control group (generic nutrition information)
Number of subjects: 1349
Study 25599828 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic intervention (risk groups)
Number of subjects: 1349
Study 25599828 — intervention group
Group type: EXPERIMENTAL
Intervention: Plus intervention (risk groups)
Number of subjects: 1349
Study 23403945 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin infusion with 100 ml 5% dextrose/h
Number of subjects: 10
Study 23403945 — intervention group
Group type: COMPARATOR
Intervention: Glucose infusion (100 ml/h)
Number of subjects: 10
Study 23403945 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline (100 ml/h)
Number of subjects: 10
Study 21054229 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous sinus mucosal lining elevation and placement of dental implants without graft materials
Number of subjects: 15
Study 21054229 — intervention group
Group type: COMPARATOR
Intervention: Simultaneous sinus mucosal lining elevation and placement of dental implants with intraoral autogenous bone graft
Number of subjects: 15
Study 20217948 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive attitude towards medication
Number of subjects: 500
Study 20217948 — intervention group
Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 500
Study 20217948 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender (Female)
Number of subjects: 500
Study 20217948 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-care orientation
Number of subjects: 500
Study 20217948 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication knowledge
Number of subjects: 500
Study 20217948 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy visits
Number of subjects: 500
Study 17124283 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate 2.5 mg/day (group B)
Number of subjects: 114
Study 17124283 — intervention group
Group type: EXPERIMENTAL
Intervention: Risedronate only (group C)
Number of subjects: 114
Study 17124283 — intervention group
Group type: COMPARATOR
Intervention: Active vitamin D only (group A)
Number of subjects: 114
Study 15507930 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal metronidazole for 5 days
Number of subjects: 119
Study 15507930 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin for 3 days
Number of subjects: 119
Study 11513817 — intervention group
Group type: EXPERIMENTAL
Intervention: 100-g amino acid (AA) drink devoid of tryptophan
Number of subjects: 39
Study 11513817 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 9635910 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam 4 g i.v. Q6H
Number of subjects: 150
Study 9635910 — intervention group
Group type: COMPARATOR
Intervention: Imipenem 500 mg i.v. Q6H
Number of subjects: 150
Study 9635910 — intervention group
Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam
Number of subjects: 150
Study 9635910 — intervention group
Group type: COMPARATOR
Intervention: Imipenem
Number of subjects: 150
Study 7828694 — intervention group
Group type: EXPERIMENTAL
Intervention: Turbuhaler
Number of subjects: 37
Study 7828694 — intervention group
Group type: COMPARATOR
Intervention: P-MDI
Number of subjects: 37
Study 3124598 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parenteral nutrition (TPN) for 10 days
Number of subjects: 0
Study 31609293 — intervention group
Group type: EXPERIMENTAL
Intervention: LBW protocol (679 mg iodine/kg for men, 762 mg iodine/kg for women)
Number of subjects: 529
Study 31609293 — intervention group
Group type: EXPERIMENTAL
Intervention: LBW protocol (620.7 mg iodine/kg)
Number of subjects: 529
Study 31609293 — intervention group
Group type: COMPARATOR
Intervention: Both LBW and TBW protocols
Number of subjects: 529
Study 29151034 — intervention group
Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin 10/40 mg
Number of subjects: 18144
Study 29151034 — intervention group
Group type: COMPARATOR
Intervention: placebo/simvastatin 40 mg
Number of subjects: 18144
Study 24882567 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin (.16 mg/kg)
Number of subjects: 25
Study 24882567 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 24882567 — intervention group
Group type: EXPERIMENTAL
Intervention: Psilocybin
Number of subjects: 25
Study 23241007 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular Protraction Appliance-IV (MPA-IV)
Number of subjects: 83
Study 23241007 — intervention group
Group type: EXPERIMENTAL
Intervention: Twin-block appliance
Number of subjects: 83
Study 23241007 — intervention group
Group type: COMPARATOR
Intervention: Class II controls
Number of subjects: 83
Study 21524241 — intervention group
Group type: EXPERIMENTAL
Intervention: OrthoCAD iQ indirect bonding (IDB)
Number of subjects: 46
Study 21524241 — intervention group
Group type: COMPARATOR
Intervention: Traditional IDB technique
Number of subjects: 46
Study 18559549 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake of flavonols (4th quartile during the trial)
Number of subjects: 0
Study 18559549 — intervention group
Group type: EXPERIMENTAL
Intervention: High intake of isoflavonoids, kaempferol, genistein, and formononetin
Number of subjects: 0
Study 18559549 — intervention group
Group type: EXPERIMENTAL
Intervention: Total flavonoid intake
Number of subjects: 0
Study 16520578 — intervention group
Group type: EXPERIMENTAL
Intervention: ST35 & Sulan moxibustion
Number of subjects: 34
Study 16520578 — intervention group
Group type: COMPARATOR
Intervention: Control group (no moxibustion)
Number of subjects: 34
Study 14567819 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol 100 mug
Number of subjects: 40
Study 14567819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 11126207 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg t.i.d. during the first year
Number of subjects: 72
Study 11126207 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat 120 mg t.i.d. during the second year
Number of subjects: 72
Study 11126207 — intervention group
Group type: COMPARATOR
Intervention: Placebo t.i.d. during the first year
Number of subjects: 72
Study 11126207 — intervention group
Group type: COMPARATOR
Intervention: Placebo t.i.d. during the second year
Number of subjects: 72
Study 11126207 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat treatment
Number of subjects: 72
Study 11126207 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 72
Study 9097890 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10mg
Number of subjects: 12
Study 9097890 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine 200 microg
Number of subjects: 12
Study 9097890 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 8246033 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallium nitrate treatment (30 mg/m2/d for 2 weeks, followed by 2 weeks off, plus 100 mg/m2/d IV for 5 days every other month)
Number of subjects: 20
Study 8246033 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallium nitrate treatment
Number of subjects: 20
Study 8246033 — intervention group
Group type: COMPARATOR
Intervention: Observation
Number of subjects: 20
Study 3513669 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketotifen 1 mg bid
Number of subjects: 30
Study 3513669 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 29044496 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin, paclitaxel, and bevacizumab (CPB)
Number of subjects: 149
Study 29044496 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin, paclitaxel, bevacizumab, and everolimus (CPBE)
Number of subjects: 149
Study 27794449 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga intervention
Number of subjects: 118
Study 27794449 — intervention group
Group type: COMPARATOR
Intervention: Stretching control
Number of subjects: 118
Study 24252050 — intervention group
Group type: EXPERIMENTAL
Intervention: iguratimod + MTX
Number of subjects: 0
Study 24252050 — intervention group
Group type: COMPARATOR
Intervention: (placebo/iguratimod) + MTX
Number of subjects: 0
Study 23507369 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg fluoxetine and high dose folic acid (5 mg/day; n=19; Group II)
Number of subjects: 42
Study 23507369 — intervention group
Group type: COMPARATOR
Intervention: 20 mg fluoxetine and low dose folic acid (1.5 mg/day; n=23; Group I)
Number of subjects: 42
Study 20797449 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxyurea (HU)
Number of subjects: 1106
Study 20797449 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (placebo-controlled)
Number of subjects: 1106
Study 18405960 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 186
Study 18405960 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured intervention
Number of subjects: 186
Study 18405960 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 186
Study 16027695 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage therapy (moderate pressure)
Number of subjects: 0
Study 16027695 — intervention group
Group type: COMPARATOR
Intervention: Sham massage (light pressure)
Number of subjects: 0
Study 14561017 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly apnoeics (EA)
Number of subjects: 44
Study 14561017 — intervention group
Group type: EXPERIMENTAL
Intervention: Young apnoeics (YA)
Number of subjects: 44
Study 14561017 — intervention group
Group type: COMPARATOR
Intervention: Elderly non-apnoeics (EN)
Number of subjects: 44
Study 14561017 — intervention group
Group type: COMPARATOR
Intervention: Young non-apnoeics (YN)
Number of subjects: 44
Study 14561017 — intervention group
Group type: EXPERIMENTAL
Intervention: Elderly apnoeics (EA) and Young apnoeics (YA)
Number of subjects: 44
Study 11199194 — intervention group
Group type: EXPERIMENTAL
Intervention: Quantitative computed tomography (QCT)
Number of subjects: 64
Study 11199194 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-energy X-ray absorptiometry (DXA)
Number of subjects: 64
Study 11199194 — intervention group
Group type: COMPARATOR
Intervention: Comparison of QCT and DXA
Number of subjects: 64
Study 8804010 — intervention group
Group type: EXPERIMENTAL
Intervention: Biocompatible membranes
Number of subjects: 2
Study 8804010 — intervention group
Group type: COMPARATOR
Intervention: Cuprophane membranes
Number of subjects: 2
Study 1629748 — intervention group
Group type: EXPERIMENTAL
Intervention: 160/800 mg b.i.d. orally x 3 days
Number of subjects: 75
Study 1629748 — intervention group
Group type: EXPERIMENTAL
Intervention: 160/800 mg i.m. x 10 days
Number of subjects: 75
Study 1629748 — intervention group
Group type: EXPERIMENTAL
Intervention: 160/800 mg b.i.d. orally x 20 days
Number of subjects: 75
Study 6396117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifonazole solution (daily for 2 weeks)
Number of subjects: 38
Study 6396117 — intervention group
Group type: COMPARATOR
Intervention: Selenium sulphide shampoo (2.5% daily for 1 week and weekly for 6 weeks)
Number of subjects: 38
Study 6396117 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifonazole solution
Number of subjects: 38
Study 31478763 — intervention group
Group type: EXPERIMENTAL
Intervention: 0/1-hour hs-cTnT protocol
Number of subjects: 3378
Study 27941065 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg daily)
Number of subjects: 81
Study 27941065 — intervention group
Group type: EXPERIMENTAL
Intervention: Evolocumab (420 mg every 2 weeks)
Number of subjects: 81
Study 27941065 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Atorvastatin and Evolocumab
Number of subjects: 81
Study 27941065 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 81
Study 25943660 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen (ACT) 20 mg/kg
Number of subjects: 9
Study 25943660 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 9
Study 25128046 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose etanercept (25 mg/wk)
Number of subjects: 834
Study 25128046 — intervention group
Group type: COMPARATOR
Intervention: Full-dose etanercept (50 mg/wk)
Number of subjects: 834
Study 25128046 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 834
Study 22561530 — intervention group
Group type: EXPERIMENTAL
Intervention: Real CPAP
Number of subjects: 65
Study 22561530 — intervention group
Group type: COMPARATOR
Intervention: Sham CPAP
Number of subjects: 65
Study 19955880 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-minute in-service education program
Number of subjects: 129
Study 19955880 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 129
Study 17602075 — intervention group
Group type: EXPERIMENTAL
Intervention: Formal psychotherapeutic support during hospital stay
Number of subjects: 271
Study 17602075 — intervention group
Group type: COMPARATOR
Intervention: Standard care as provided on the surgical wards
Number of subjects: 271
Study 15841578 — intervention group
Group type: EXPERIMENTAL
Intervention: CeraOne abutments (Nobel Biocare AB)
Number of subjects: 18
Study 15841578 — intervention group
Group type: EXPERIMENTAL
Intervention: Procera ceramic abutments (Nobel Biocare AB)
Number of subjects: 18
Study 15841578 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 18
Study 16115972 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure at the Yintang point
Number of subjects: 61
Study 16115972 — intervention group
Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 61
Study 16115972 — intervention group
Group type: COMPARATOR
Intervention: Acupressure and Sham
Number of subjects: 61
Study 10341165 — intervention group
Group type: COMPARATOR
Intervention: D‐tagatose
Number of subjects: 50
Study 10341165 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 50
Study 10341165 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose
Number of subjects: 50
Study 8583588 — intervention group
Group type: EXPERIMENTAL
Intervention: High water intake (group 1)
Number of subjects: 199
Study 8583588 — intervention group
Group type: COMPARATOR
Intervention: No treatment (group 2)
Number of subjects: 199
Study 1759956 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy (CBT)
Number of subjects: 0
Study 1759956 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy with exposure and response prevention (CBT + ERP)
Number of subjects: 0
Study 7047984 — intervention group
Group type: EXPERIMENTAL
Intervention: Acarbose (100 mg p.o.)
Number of subjects: 6
Study 7047984 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100 mg p.o.)
Number of subjects: 6
Study 30892782 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol and ketamine (KP group)
Number of subjects: 81
Study 30892782 — intervention group
Group type: COMPARATOR
Intervention: Propofol monosedation (Pm group)
Number of subjects: 81
Study 30892782 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 81
Study 30071784 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance care planning (ACP) event
Number of subjects: 188
Study 26853953 — intervention group
Group type: EXPERIMENTAL
Intervention: Prompt revascularization (PR) with intensive medical therapy (IMT)
Number of subjects: 2368
Study 26853953 — intervention group
Group type: COMPARATOR
Intervention: Intensive medical therapy (IMT) alone
Number of subjects: 2368
Study 26853953 — intervention group
Group type: COMPARATOR
Intervention: Non-CTO group
Number of subjects: 2368
Study 24045979 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual misoprostol (600 μg)
Number of subjects: 100
Study 24045979 — intervention group
Group type: COMPARATOR
Intervention: Intravenous oxytocin (10 IU)
Number of subjects: 100
Study 20977608 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial overdentures supported with single immediately loaded implant in symphyseal region
Number of subjects: 12
Study 20977608 — intervention group
Group type: COMPARATOR
Intervention: Removable metallic partial denture
Number of subjects: 12
Study 20919774 — intervention group
Group type: EXPERIMENTAL
Intervention: Ingroup faces
Number of subjects: 0
Study 20919774 — intervention group
Group type: COMPARATOR
Intervention: Outgroup faces
Number of subjects: 0
Study 17141741 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholinergic medication (acetylcholinesterase inhibitor)
Number of subjects: 107
Study 17141741 — intervention group
Group type: EXPERIMENTAL
Intervention: REM sleep augmentation (physiological rebound)
Number of subjects: 107
Study 17141741 — intervention group
Group type: COMPARATOR
Intervention: REM sleep deprivation (via REM sleep awakenings)
Number of subjects: 107
Study 17141741 — intervention group
Group type: COMPARATOR
Intervention: Non-REM sleep awakenings
Number of subjects: 107
Study 15860521 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 8 mg once daily
Number of subjects: 1502
Study 15860521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1502
Study 12221896 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate aqueous nasal spray, 200 mcg once daily
Number of subjects: 206
Study 12221896 — intervention group
Group type: COMPARATOR
Intervention: Placebo vehicle
Number of subjects: 206
Study 10461471 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular hyaluronic acid (HA)
Number of subjects: 100
Study 10461471 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 7828381 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg S‐nitrendipine
Number of subjects: 6
Study 7828381 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg racemic nitrendipine
Number of subjects: 6
Study 7828381 — intervention group
Group type: COMPARATOR
Intervention: 20 mg R‐nitrendipine
Number of subjects: 6
Study 7828381 — intervention group
Group type: COMPARATOR
Intervention: 80 mg R‐nitrendipine
Number of subjects: 6
Study 7828381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 26101836 — intervention group
Group type: EXPERIMENTAL
Intervention: High-frequency TENS (HF-TENS)
Number of subjects: 15
Study 26101836 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-frequency TENS (LF-TENS)
Number of subjects: 15
Study 26101836 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS (P-TENS)
Number of subjects: 15
Study 23519225 — intervention group
Group type: EXPERIMENTAL
Intervention: Galantamine
Number of subjects: 39